Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases
Over the past years, RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a tool to identify new targets for therapeutic intervention. This review focuses on the current understanding of RNAi biology,...
Gespeichert in:
| Veröffentlicht in: | Endocrinology (Philadelphia) 2006-06, Vol.147 (6), p.2650-2656 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2656 |
|---|---|
| container_issue | 6 |
| container_start_page | 2650 |
| container_title | Endocrinology (Philadelphia) |
| container_volume | 147 |
| creator | Rondinone, Cristina M |
| description | Over the past years, RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a tool to identify new targets for therapeutic intervention. This review focuses on the current understanding of RNAi biology, how RNAi has been used to study the role of different genes in the pathogenesis of diabetes and obesity, and the use of RNAi screens for the identification of new targets for metabolic diseases. Also reviewed are the in vivo proof of principle experiments that provide the validation of these new targets for the development of RNAi-based therapeutics for diabetes. |
| doi_str_mv | 10.1210/en.2006-0147 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67977521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2006-0147</oup_id><sourcerecordid>67977521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-422f11710f9f16381bd5d26a1cd38f37c45fca5e3a3bb6bcf770b2d1b4cc6fc23</originalsourceid><addsrcrecordid>eNp10cFrFDEUBvAgil2rN88yIOrFqXnJJNn1Vqq1C62CrOeQybxoymyyTTIu_vedYYcuiJ5C4Mf3XvIR8hLoGTCgHzCcMUplTaFRj8gCVo2oFSj6mCwoBV4rxtQJeZbz7XhtmoY_JScghZBKrBZkf-ODT_jb4_5j9d23MQy2R2-rc-u7ah0KJocJg8XKxVSVX1itOwzFO29N8TFU0VVfcV9tTPqJJT-oTUJTtqOcwA0W08Z-jP3kM5qM-Tl54kyf8cV8npIfl583F1f19bcv64vz69oKpkrdMOYAFFC3ciD5EtpOdEwasB1fOq5sI5w1ArnhbStb65SiLeugbayVzjJ-St4ecncp3g2Yi976bLHvTcA4ZC3VSinBYISv_4K3cUhh3E1z4FQo2chJvT8om2LOCZ3eJb816Y8Gqqc6NAY91aGnOkb-ag4d2i12Rzz__wjezMBka3qXTLA-H51aCuBCjO7dwcVh97-R9TySHySGLtrkA-4S5nx8zT8XvQfwr7AA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130576461</pqid></control><display><type>article</type><title>Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rondinone, Cristina M</creator><creatorcontrib>Rondinone, Cristina M</creatorcontrib><description>Over the past years, RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a tool to identify new targets for therapeutic intervention. This review focuses on the current understanding of RNAi biology, how RNAi has been used to study the role of different genes in the pathogenesis of diabetes and obesity, and the use of RNAi screens for the identification of new targets for metabolic diseases. Also reviewed are the in vivo proof of principle experiments that provide the validation of these new targets for the development of RNAi-based therapeutics for diabetes.</description><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2006-0147</identifier><identifier>PMID: 16556759</identifier><identifier>CODEN: ENDOAO</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adenoviridae - genetics ; Agouti-Related Protein ; Animals ; Apolipoproteins B - genetics ; Biological and medical sciences ; Diabetes mellitus ; Diabetes Mellitus - therapy ; Drug development ; Early Growth Response Protein 1 - genetics ; Fundamental and applied biological sciences. Psychology ; Gene expression ; Humans ; In vivo methods and tests ; Insulin - physiology ; Insulin Receptor Substrate Proteins ; Intercellular Signaling Peptides and Proteins ; Metabolic disorders ; Obesity - therapy ; Pathogenesis ; Phosphoproteins - genetics ; Proteins - genetics ; RNA Interference ; RNA-mediated interference ; Signal Transduction ; Target acquisition ; Target recognition ; Transcription Factors - genetics ; Vertebrates: endocrinology</subject><ispartof>Endocrinology (Philadelphia), 2006-06, Vol.147 (6), p.2650-2656</ispartof><rights>Copyright © 2006 by the Endocrine Society 2006</rights><rights>2006 INIST-CNRS</rights><rights>Copyright © 2006 by the Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-422f11710f9f16381bd5d26a1cd38f37c45fca5e3a3bb6bcf770b2d1b4cc6fc23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17851355$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16556759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rondinone, Cristina M</creatorcontrib><title>Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><description>Over the past years, RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a tool to identify new targets for therapeutic intervention. This review focuses on the current understanding of RNAi biology, how RNAi has been used to study the role of different genes in the pathogenesis of diabetes and obesity, and the use of RNAi screens for the identification of new targets for metabolic diseases. Also reviewed are the in vivo proof of principle experiments that provide the validation of these new targets for the development of RNAi-based therapeutics for diabetes.</description><subject>Adenoviridae - genetics</subject><subject>Agouti-Related Protein</subject><subject>Animals</subject><subject>Apolipoproteins B - genetics</subject><subject>Biological and medical sciences</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - therapy</subject><subject>Drug development</subject><subject>Early Growth Response Protein 1 - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>Humans</subject><subject>In vivo methods and tests</subject><subject>Insulin - physiology</subject><subject>Insulin Receptor Substrate Proteins</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Metabolic disorders</subject><subject>Obesity - therapy</subject><subject>Pathogenesis</subject><subject>Phosphoproteins - genetics</subject><subject>Proteins - genetics</subject><subject>RNA Interference</subject><subject>RNA-mediated interference</subject><subject>Signal Transduction</subject><subject>Target acquisition</subject><subject>Target recognition</subject><subject>Transcription Factors - genetics</subject><subject>Vertebrates: endocrinology</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10cFrFDEUBvAgil2rN88yIOrFqXnJJNn1Vqq1C62CrOeQybxoymyyTTIu_vedYYcuiJ5C4Mf3XvIR8hLoGTCgHzCcMUplTaFRj8gCVo2oFSj6mCwoBV4rxtQJeZbz7XhtmoY_JScghZBKrBZkf-ODT_jb4_5j9d23MQy2R2-rc-u7ah0KJocJg8XKxVSVX1itOwzFO29N8TFU0VVfcV9tTPqJJT-oTUJTtqOcwA0W08Z-jP3kM5qM-Tl54kyf8cV8npIfl583F1f19bcv64vz69oKpkrdMOYAFFC3ciD5EtpOdEwasB1fOq5sI5w1ArnhbStb65SiLeugbayVzjJ-St4ecncp3g2Yi976bLHvTcA4ZC3VSinBYISv_4K3cUhh3E1z4FQo2chJvT8om2LOCZ3eJb816Y8Gqqc6NAY91aGnOkb-ag4d2i12Rzz__wjezMBka3qXTLA-H51aCuBCjO7dwcVh97-R9TySHySGLtrkA-4S5nx8zT8XvQfwr7AA</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Rondinone, Cristina M</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases</title><author>Rondinone, Cristina M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-422f11710f9f16381bd5d26a1cd38f37c45fca5e3a3bb6bcf770b2d1b4cc6fc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenoviridae - genetics</topic><topic>Agouti-Related Protein</topic><topic>Animals</topic><topic>Apolipoproteins B - genetics</topic><topic>Biological and medical sciences</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - therapy</topic><topic>Drug development</topic><topic>Early Growth Response Protein 1 - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>Humans</topic><topic>In vivo methods and tests</topic><topic>Insulin - physiology</topic><topic>Insulin Receptor Substrate Proteins</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Metabolic disorders</topic><topic>Obesity - therapy</topic><topic>Pathogenesis</topic><topic>Phosphoproteins - genetics</topic><topic>Proteins - genetics</topic><topic>RNA Interference</topic><topic>RNA-mediated interference</topic><topic>Signal Transduction</topic><topic>Target acquisition</topic><topic>Target recognition</topic><topic>Transcription Factors - genetics</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rondinone, Cristina M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rondinone, Cristina M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>147</volume><issue>6</issue><spage>2650</spage><epage>2656</epage><pages>2650-2656</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><coden>ENDOAO</coden><abstract>Over the past years, RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a tool to identify new targets for therapeutic intervention. This review focuses on the current understanding of RNAi biology, how RNAi has been used to study the role of different genes in the pathogenesis of diabetes and obesity, and the use of RNAi screens for the identification of new targets for metabolic diseases. Also reviewed are the in vivo proof of principle experiments that provide the validation of these new targets for the development of RNAi-based therapeutics for diabetes.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>16556759</pmid><doi>10.1210/en.2006-0147</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0013-7227 |
| ispartof | Endocrinology (Philadelphia), 2006-06, Vol.147 (6), p.2650-2656 |
| issn | 0013-7227 1945-7170 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67977521 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adenoviridae - genetics Agouti-Related Protein Animals Apolipoproteins B - genetics Biological and medical sciences Diabetes mellitus Diabetes Mellitus - therapy Drug development Early Growth Response Protein 1 - genetics Fundamental and applied biological sciences. Psychology Gene expression Humans In vivo methods and tests Insulin - physiology Insulin Receptor Substrate Proteins Intercellular Signaling Peptides and Proteins Metabolic disorders Obesity - therapy Pathogenesis Phosphoproteins - genetics Proteins - genetics RNA Interference RNA-mediated interference Signal Transduction Target acquisition Target recognition Transcription Factors - genetics Vertebrates: endocrinology |
| title | Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minireview:%20Ribonucleic%20Acid%20Interference%20for%20the%20Identification%20of%20New%20Targets%20for%20the%20Treatment%20of%20Metabolic%20Diseases&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Rondinone,%20Cristina%20M&rft.date=2006-06-01&rft.volume=147&rft.issue=6&rft.spage=2650&rft.epage=2656&rft.pages=2650-2656&rft.issn=0013-7227&rft.eissn=1945-7170&rft.coden=ENDOAO&rft_id=info:doi/10.1210/en.2006-0147&rft_dat=%3Cproquest_cross%3E67977521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130576461&rft_id=info:pmid/16556759&rft_oup_id=10.1210/en.2006-0147&rfr_iscdi=true |